We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

47 hedge funds and large institutions have $6.64M invested in PDS Biotechnology in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.35% less ownership

Funds ownership: 16.3% → 11.95% (-4.3%)

15% less funds holding

Funds holding: 55 → 47 (-8)

33% less capital invested

Capital invested by funds: $9.9M → $6.64M (-$3.26M)

36% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 14

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

Holders
47
Holders Change
-8
Holders Change %
-14.55%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
14
Closed
15
Calls
$321K
Puts
–
Net Calls
+$321K
Net Calls Change
+$87K

Top Buyers

Rank Fund Capital Flow
1
IWA
Inspirion Wealth Advisors
Illinois
+$313K
2
Squarepoint
Squarepoint
New York
+$228K
3
Renaissance Technologies
Renaissance Technologies
New York
+$200K
4
Citadel Advisors
Citadel Advisors
Florida
+$162K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$95.1K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.97M
2
UBS Group
UBS Group
Switzerland
-$403K
3
Millennium Management
Millennium Management
New York
-$108K
4
Marshall Wace
Marshall Wace
United Kingdom
-$91K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$58.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Raymond James Financial
26
Raymond James Financial
Florida
$13.9K -$105 -89 -0.6%
Mercer Global Advisors
27
Mercer Global Advisors
Colorado
$12.6K -$12 -10 -0.1%
Simplex Trading
28
Simplex Trading
Illinois
$12K +$14.6K +12,405 New
SWP
29
Stratos Wealth Partners
Ohio
$11.4K – – –
JWBC
30
J.W. Burns & Co
New York
$10.4K – – –
GD
31
Grandfield & Dodd
New York
$10.1K – – –
Morgan Stanley
32
Morgan Stanley
New York
$8.34K +$970 +825 +11%
KSWA
33
Kathleen S. Wright Associates
Pennsylvania
$7.07K – – –
BBA
34
Baader Bank Aktiengesellschaft
Germany
$6.57K +$12.4K +10,528 New
Wells Fargo
35
Wells Fargo
California
$5.38K – – –
CFD
36
Creative Financial Designs
Indiana
$3.03K – – –
Jones Financial Companies
37
Jones Financial Companies
Missouri
$2.04K +$2.35K +2,000 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$2K -$6.21K -5,281 -74%
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$1.15K -$2 -2 -0.2%
Bank of America
40
Bank of America
North Carolina
$1.05K +$457 +389 +60%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$1.02K -$22 -19 -2%
TC
42
Truvestments Capital
Florida
$662 -$536 -456 -41%
JP Morgan Chase
43
JP Morgan Chase
New York
$625 – – –
RWM
44
Rialto Wealth Management
New York
$404 – – –
SS
45
SBI Securities
Japan
$111 -$114 -97 -47%
Citigroup
46
Citigroup
New York
$24 +$28 +24 New
Osaic Holdings
47
Osaic Holdings
Arizona
$17 -$588 -500 -97%
AC
48
Armistice Capital
New York
– -$2.97M -2,236,000 Closed
Millennium Management
49
Millennium Management
New York
– -$108K -81,449 Closed
Marshall Wace
50
Marshall Wace
United Kingdom
– -$91K -68,454 Closed
1
2
3

PDSB Hedge Fund Activity: Q3 2025 in Review

47 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q3 2025, worth a combined $6.64M — down 33% from $9.9M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of PDSB and 8 opened new positions — a net loss of 7 holders — while 14 trimmed existing stakes and 9 added.

The largest buyer was Inspirion Wealth Advisors, adding an estimated $313K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.97M sold.

  • 47 institutional investors held PDS Biotechnology (PDSB) as of Q3 2025, down from 55 in Q2 2025.
  • Funds reported $6.64M of PDS Biotechnology stock for Q3 2025, down 33% quarter-over-quarter.
  • 8 funds opened new PDS Biotechnology positions in Q3 2025 and 15 closed out, a net change of -7 holders.
  • The largest PDS Biotechnology buyer in Q3 2025 was Inspirion Wealth Advisors, an estimated $313K added.
  • The largest PDS Biotechnology seller in Q3 2025 was Armistice Capital, an estimated $2.97M sold.

Based on aggregated 13F filings for Q3 2025.